Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 134.86 USD | -1.03% |
|
-5.94% | +54.41% |
| Market Cap | 8.8B 7.93B 7.33B 6.63B 12.54B 826B 12.85B 87.84B 35.01B 442B 33.04B 32.33B 1,407B | P/E 2026 * |
26.7x | P/E 2027 * | 667x |
|---|---|---|---|---|---|
| Enterprise Value | 8.23B 7.41B 6.85B 6.19B 11.72B 772B 12B 82.09B 32.72B 413B 30.87B 30.22B 1,315B | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 34.3x |
| Free-Float |
96.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -1.03% | ||
| 1 week | -5.94% | ||
| Current month | -6.90% | ||
| 1 month | -6.17% | ||
| 3 months | -9.06% | ||
| 6 months | +30.30% | ||
| Current year | +54.41% |
| 1 week | 128 |  | 138.4 |
| 1 month | 126.39 | | 146.44 |
| Current year | 77 | | 160.81 |
| 1 year | 77 | | 160.81 |
| 3 years | 15.05 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 68 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 175,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.03% | -5.94% | +57.62% | +770.63% | 8.89B | |
| -1.06% | -0.07% | +60.76% | +68.61% | 68.32B | |
| +1.30% | +7.41% | +14.79% | +92.69% | 60.26B | |
| +0.39% | +0.30% | +20.04% | +98.33% | 55.86B | |
| -0.95% | +11.17% | +22.21% | +110.93% | 48.43B | |
| -0.23% | +4.07% | +25.63% | +40.08% | 45.34B | |
| -6.40% | -9.51% | +181.99% | +816.79% | 41.76B | |
| +1.97% | +3.50% | +25.78% | +50.98% | 34.5B | |
| -0.56% | -0.48% | +85.57% | +65.40% | 33.8B | |
| +0.08% | +0.74% | +47.00% | +0.49% | 25.96B | |
| Average | -0.62% | +1.26% | +54.14% | +211.49% | 42B | |
| Weighted average by Cap. | -0.59% | +1.62% | +50.84% | +160.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 566M 510M 472M 426M 806M 53.11B 826M 5.65B 2.25B 28.44B 2.13B 2.08B 90.52B | 240M 217M 200M 181M 342M 22.53B 351M 2.4B 956M 12.07B 902M 882M 38.4B |
| Net income | 353M 318M 294M 266M 502M 33.09B 515M 3.52B 1.4B 17.72B 1.32B 1.3B 56.4B | 32.9M 29.65M 27.4M 24.77M 46.86M 3.09B 48.01M 328M 131M 1.65B 123M 121M 5.26B |
| Net Debt | -576M -519M -480M -434M -821M -54.05B -841M -5.75B -2.29B -28.95B -2.16B -2.12B -92.11B | -567M -511M -472M -427M -808M -53.19B -828M -5.66B -2.26B -28.49B -2.13B -2.08B -90.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$134.86 | -1.03% | 332,589 |
| 10/11/26 | US$136.26 | +0.26% | 528,491 |
| 09/11/26 | US$135.90 | +2.92% | 607,111 |
| 06/11/26 | US$132.04 | -2.38% | 972,945 |
| 05/11/26 | US$135.26 | -5.66% | 584,678 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
